Crossmark

The Therapeutic Efficacy of MS473, a Fully Human Single-Chain Variable Fragment Targeting Staphylococcus aureus Toxic Shock Syndrome Toxin-1, in a D-Galactosamine-Sensitized Mouse Model of Lethal Shock

Crossref DOI link: https://doi.org/10.1186/s12866-025-03825-8

Published Online: 2025-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahimi-Jamnani, Fatemeh

Moradi, Hamid Reza

Fateh, Abolfazl

Azizi, Masoumeh

Nazari, Farzaneh

Soezi, Mahdieh

Siadat, Seyed Davar
License Information

Text and Data Mining valid from 2025-02-26

Version of Record valid from 2025-02-26
More Information

Article History

Received: 21 August 2024

Accepted: 13 February 2025

First Online: 26 February 2025

Declarations

:

: Animal experiments were conducted in accordance with ARRIVE guidelines ( ) and approved by the Animal Care and Use Committees of the Pasteur Institute of Iran (IR.PII.REC.1398.028). All methods were performed in accordance with relevant guidelines and regulations.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below